SEC Filings
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
| Filing date | Form | Description | Filing Group | View |
|---|---|---|---|---|
| 8-K |
Report of unscheduled material events or corporate event |
Current Reports
|
||
| 10-Q |
Quarterly report which provides a continuing view of a company's financial position |
Quarterly Filings
|
||
| 424B3 |
Form of prospectus reflecting facts events constituting substantive change from last form |
Registration Statements
|
||
| DEF 14A |
Official notification to shareholders of matters to be brought to a vote ("Proxy") |
Proxy Filings
|
||
| DEFA14A |
Additional proxy soliciting materials - definitive |
Proxy Filings
|
||
| ARS |
An annual report to security holders |
Annual Filings
|
||
| 4 |
Statement of changes in beneficial ownership of securities |
3,4,5
|
||
| SC 13D/A |
An amendment to a SC 13D filing |
Other
|
||
| EFFECT |
EFFECT |
Other
|
||
| CORRESP |
CORRESP |
Other
|
Displaying 1 - 10 of 455 results
Data provided by Kaleidoscope.